The non-vesicle cell-free DNA (cfDNA) induces cell transformation associated with horizontal DNA transfer
D. A. De La Cruz-Sigüenza,J. P. Reyes-Grajeda,M. A. Velasco-Velázquez,C. Trejo-Becerril,E. Pérez-Cárdenas,A. Chávez-Blanco,L. Taja-Chayeb,G. Domínguez-Gómez,M. P. Ramos-Godinez,A. González-Fierro,A. Dueñas-González
DOI: https://doi.org/10.1007/s11033-023-09016-w
IF: 2.7422
2024-01-22
Molecular Biology Reports
Abstract:Abstract Background Cell-free DNA (cfDNA) is a source for liquid biopsy used for cancer diagnosis, therapy selection, and disease monitoring due to its non-invasive nature and ease of extraction. However, cfDNA also participates in cancer development and progression by horizontal transfer. In humans, cfDNA circulates complexed with extracellular vesicles (EV) and macromolecular complexes such as nucleosomes, lipids, and serum proteins. The present study aimed to demonstrate whether cfDNA not associated with EV induces cell transformation and tumorigenesis. Methods Supernatant of the SW480 human colon cancer cell line was processed by ultracentrifugation to obtain a soluble fraction (SF) and a fraction associated with EV (EVF). Primary murine embryonic fibroblast cells (NIH3T3) underwent passive transfection with these fractions, and cell proliferation, cell cycle, apoptosis, cell transformation, and tumorigenic assays were performed. Next, cfDNA was analyzed by electronic microscopy, and horizontal transfer was assessed by human mutant KRAS in recipient cells via PCR and recipient cell internalization via fluorescence microscopy. Results The results showed that the SF but not the EVF of cfDNA induced proliferative and antiapoptotic effects, cell transformation, and tumorigenesis in nude mice, which were reduced by digestion with DNAse I and proteinase K. These effects were associated with horizontal DNA transfer and cfDNA internalization into recipient cells. Conclusions The results suggest pro-tumorigenic effects of cfDNA in the SF that can be offset by enzyme treatment. Further exploration of the horizontal tumor progression phenomenon mediated by cfDNA is needed to determine whether its manipulation may play a role in cancer therapy.
biochemistry & molecular biology